Arvid E. Gollwitzer
Founder/CEOFounder @ Anto Bio | Researcher @ Broad, Harvard, MIT | Lecturer @ ETH Zurich
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures. Founded by Arvid (Broad Institute of MIT and Harvard; Nature-publi
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures.
Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.
Previously Anto
Founder @ Anto Bio | Researcher @ Broad, Harvard, MIT | Lecturer @ ETH Zurich
Co-founder @ Anto. Formerly Janssen Pharmaceuticals, ETH Zurich and Gastroenterology Dept. of BWH, Harvard Medical School.
Founded 2025 · Source
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.